The Vanguard Group, Inc. recently announced the acquisition of new stake in Physicians Realty Trust (NYSE:DOC). The institutional investor has increased its shareholding in the Real Estate company by 0.09% to 26.98 million shares with purchase of 23073.0 shares. This fresh investment now brings its stake to 13.32% valued currently at $472.75 million. In addition, BlackRock Fund Advisors raised its holdings by 0.12 million to 15.29 million shares. And AllianceBernstein LP has lifted its position by 530.60% or 5.53 million shares – to 6.57 million shares.
With over 1.29 million Physicians Realty Trust (DOC) shares trading Tuesday and a closing price of $17.75 on the day, the dollar volume was approximately $22.95 million. The shares have shown a positive weekly performance of 4.47% and its price on 07/28/20 gained nearly 0.57%. Currently, there are 202.56M common shares owned by the public and among those 201.01M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 15 analysts who have offered their price forecasts for DOC have a consensus price objective of $18.93. The analysts have set the share’s price value over the next 12 months at a high of $21.00 and a low of $17.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Physicians Realty Trust stock is 2.20 for the next 12 months. The average price target is 4.21% above its last price level and an upside to the estimated low will see the stock lose -4.41% over that period. But an upside of 15.48% will see the stock hit the forecast high price target while mean target price for the stock is $19.00.
Insiders at the company have transacted a total of 68 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 39 of these insider trades were purchases, accounting for 366,223 shares. Insider sales of the common stock occurred on 29 occasions, with total insider shares sold totaling 203,612 shares.
The top 3 mutual fund holders in Physicians Realty Trust are Vanguard Real Estate Index Fund, Vanguard Total Stock Market Index, and iShares Core S&P Mid Cap ETF. Vanguard Real Estate Index Fund owns 8.85 million shares of the company’s stock, all valued at over $155.0 million. The company bought an additional 86761.0 shares recently to bring their total holdings to about 4.37% of the shares outstanding. Vanguard Total Stock Market Index bought 0.36 million shares to see its total holdings expand to 5.79 million shares valued at over $101.36 million and representing 2.86% of the shares outstanding. iShares Core S&P Mid Cap ETF now owns shares totaling to 2.69% of the shares outstanding.
Shares of Physicians Realty Trust (NYSE: DOC) opened at $17.55, down -$0.1 from a prior closing price of $17.65. However, the script later closed the day at $17.75, up 0.57%. The company’s stock has a 5-day price change of 4.47% and 16.32% over the past three months. DOC shares are trading -6.28% year to date (YTD), with the 12-month market performance up to 3.44% higher. It has a 12-month low price of $11.01 and touched a high of $20.78 over the same period. Currently, 1.29 million shares have been traded, compared to an average intraday trading volume of 3.13 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.03%, 1.93%, and 0.64% respectively.
Institutional ownership of Physicians Realty Trust (NYSE: DOC) shares accounts for 93.60% of the company’s 202.56M shares outstanding. Mutual fund holders own 37.66%, while other institutional holders and individual stakeholders account for 54.61% and 0.80% respectively.
It has a market capitalization of $3.62B and a beta (3y monthly) value of 0.80. The stock’s trailing 12-month PE ratio is 44.04, while the earnings-per-share (ttm) stands at $0.40. The company has a PEG of 4.54 and the debt-to-equity ratio at 0.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.18% over the week and 2.95% over the month.
Analysts forecast that Physicians Realty Trust (DOC) will achieve an EPS of $0.07 for the current quarter, $0.08 for the next quarter and $0.34 for 2021. The lowest estimate earnings-per-share for the quarter is $0.06 while analysts give the company a high EPS estimate of $0.08. Comparatively, EPS for the current quarter was $0.04 a year ago. Earnings per share for the fiscal year are expected to increase by 30.70%, and 8.57% over the next financial year. EPS should shrink at an annualized rate of 9.70% over the next five years, compared to 39.20% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 15 brokerage firm advisors rate Physicians Realty Trust (DOC) as a “Moderate Buy” at a consensus score of 2.20. Specifically, 7 Wall Street analysts polled rate the stock as a buy, while 5 of the 15 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the DOC, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on April 07, 2020, with the firm’s price target at $21-$14. Berenberg coverage for the Physicians Realty Trust (DOC) stock in a research note released on April 01, 2020 offered a Buy rating with a price target of. BTIG Research was of a view on March 16, 2020 that the stock is Neutral, while BMO Capital Markets gave the stock Outperform rating on March 09, 2020, issuing a price target of $19- $23. CapitalOne on their part issued Overweight rating on February 27, 2020.